Nevada could become the first state in the United States. to allow all residents to buy into the Medicaid program, no matter what their income level. The state's legislature passed the bill earlier this month, but the final decision rests with Republican governor Brian Sandoval, who has the power...

Endo International is reviewing a request from the US Food & Drug Administration (FDA) to remove the opioid pain medication Opana ER (oxymorphone hydrochloride extended release) from the market. The government body's Drug Safety Risk Management and Anesthetic and Analgesic Drug Products...

The US Food & Drug Administration (FDA) has approved a generic form of Eli Lilly and Company's Strattera (atomoxetine), used to treat patients with attention-deficit/hyperactivity disorder (ADHD). The generic non-stimulant ADHD medication will be brought to market by Apotex Inc., Teva...

A Phase III OlympiAD trial of Lynparza (olaparib) tablets for treating patients with HER2-negative gBRCA-mutated metastatic breast cancer has yielded positive results with a "statistically-significant and clinically-meaningful improvement in progression-free survival". Pharmaceutical firm...

Many patients with chronic obstructive pulmonary disease (COPD) who have Medicare Part D struggle to pay for medication and inhalers, it has been suggested. A report published in the Journal of the American Medical Association (JAMA) revealed one in nine Medicare beneficiaries have COPD. The...

A topical ocular cetirizine formulation has gained US Food & Drug Administration (FDA) New Drug Application approval for treating allergic conjunctivitis. Zerviate (cetirizine ophthalmic solution 0.24%) was developed by ophthalmic research and development company Nicox. The new topical...

Lupin Pharmaceuticals has announced the voluntary recall of a batch of Mibelas 24 Fe (norethindrone acetate and ethinylestradiol) 1mg/0.02mg chewable tablets and ferrous fumarate 75 mg) tablets. The medication is a oral contraceptive and taking the tablets in an incorrect order may place users at...

Late spring and early summer are the toughest times of the year for many patients suffering from grass allergies and hay fever. Grasses and plants release grains of pollen to fertilize other plants, but many people struggle with allergic reactions to these pollens. These cause uncomfortable...

The US Food & Drug Administration's (FDA) decision to approve a medication to treat patients whose cancer has a specific genetic feature, or biomarker, has been hailed as an "important first" in the fight against the disease. Keytruda (pembrolizumab) is a monoclonal antibody already in use to...

Sanofi and Regeneron Pharmaceuticals have gained approval from the US Food & Drug Administration (FDA) for use of Kevzara (sarilumab) for treating patients with rheumatoid arthritis. The prescription medication will be available to patients who do not respond to, or are intolerant, to disease...

An estimated 119 million Americans over the age of 12 take prescription medication, according to figures from the National Survey on Drug Use and Health. However, many struggle with the rising cost of their medicine, even those with health insurance to help them afford the required...

Over the last 12 months, one-quarter of Americans have experienced an increase in the cost of their prescription medication, according to Consumer Reports. The organization's Best Buy Drugs Prescription Costs and Concerns nationally representative survey found six out of ten patients with rising...

Non-small cell lung cancer (NSCLC) patients have a new treatment available following the US Food & Drug Administration's (FDA's) approval of Alunbrig (brigatinib). The Takeda Pharmaceuticals medication received Accelerated Approval for treatment of patients with anapestic lymphoma...

Patients with hypertension now have a cheaper medication option following the US Food & Drug Administration's approval of generic olmesartan medoxomil and hydrochlorothiazide tablets.  Aurobindo Pharma USA's latest addition to pharmacies across the country was previously only available as...

If you are one of the millions of Americans struggling with depression, discussing talk therapy and prescription antidepressant medication options with your doctor is one of the first steps to controlling the condition. Beth Salcedo, MD, medical director at the Center for Anxiety and Related...

Osteoarthritis of the hands is likely to affect up to four in ten people during their lifetime and obesity may increase the risk of developing the condition, a new study has found. Osteoarthritis is the most common form of arthritis, affecting more than 30 million people across the...

The US Food & Drug Administration (FDA) has approved the first new treatment for patients with amyotrophic lateral sclerosis (ALS) in 22 years. FDA approval for Radicava (edaravone) was granted following a six-month trial in Japan in which patients given the drug exhibited a slower rate of...

A generic version of the cholesterol-lowering medication Vytorin has been launched by Teva Pharmaceutical Industries, bringing another cheaper statin medication to US pharmacies. Vytorin is an HMG-COA reductase inhibitor/statin with a lipid modifying agent developed by Merck.  IMS data from...

Insured patients may lose prescription drug cover following yesterday's passing of the American Health Care Act (AHCA) by the US House of Representatives. The legislation includes provisions allowing states to opt out of certain protections offered under the Affordable Care Act (ACA). If passed by...

Patients have been warned be mindful about possible interactions between their prescription medication and over-the-counter (OTC) drugs. Almost seven in ten Americans are on at least one prescription medicine, according to researchers at the Mayo Clinic and Olmsted Medical Center. A leading...